With nearly 2 million Americans battling type 1 diabetes, it is no surprise that clinical therapies for the disease are constantly evolving and improving. In type 1 diabetes mellitus, the body's immune system attacks and ...
Dec 16, 2020
0
39
Hours after Margaret Keenan, a 90-year-old grandmother from the United Kingdom, became the first person to get the COVID-19 vaccine, anti-vaxxers claimed she didn't exist, that she was dead and that she was part of a Bill ...
Dec 10, 2020
0
5
A new poll conducted by the Jubilee Centre for Character and Virtues at the University of Birmingham has found that over 70% of parents worry about the risks as well as the physical and mental health implications of their ...
Dec 3, 2020
0
2
With much of the U.K. just emerging from its second coronavirus 'lockdown' into new tiers, the amount of social contact we are able to have is still limited. Among the worst affected are people living in the country's care ...
Dec 3, 2020
0
0
New research confirms men and teens are affected by Instagram influencers who set global benchmarks for ideal body shape, fashion and even facial trends.
Nov 30, 2020
1
5
To improve safety at train stations and tackle busy hotspots, ProRail, the authority that runs the Dutch rail infractructure, anonymously measures crowd dynamics of travelers. Eindhoven University of Technology (TU/e) assists ...
Nov 24, 2020
0
1
The COVID-19 pandemic is leading a Purdue University innovator to make changes as she works to provide new options for people with Parkinson's disease.
Nov 24, 2020
0
9
Vaccines are one of society's greatest success stories, but like any treatment, there can be rare adverse events and they must be tested carefully. With a massive COVID-19 vaccination campaign on the horizon, Canadian researchers ...
Nov 18, 2020
0
0
Maximizing the efficiency of the adeno-associated virus (AAV) platform for gene therapy is the aim of a new pilot project of the National Institutes of Health (NIH). The NIH Platform Vector Gene Therapy (PaVe-GT) project ...
Nov 18, 2020
0
2
The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and the human cell surface protein ACE2. To enable the virus to hook onto the cell surface, the spike protein binds ACE2 using ...
Nov 4, 2020
0
261
